title: Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').
abstract: The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15-21 July 2005. Major outcomes included the elimination of the non-specific term "chronic allograft nephropathy" (CAN) from the Banff classification for kidney allograft pathology, and the recognition of the entity of chronic antibody-mediated rejection. Participation of B cells in allograft rejection and genomics markers of rejection were also major subjects addressed by the conference.
authors.affiliation: University of Alberta, Edmonton, Alberta, Canada. Kim.Solez@ualberta.ca
authors.forename: K
authors.initials: K
authors.lastname: Solez
authors.forename: R B
authors.initials: RB
authors.lastname: Colvin
authors.forename: L C
authors.initials: LC
authors.lastname: Racusen
authors.forename: B
authors.initials: B
authors.lastname: Sis
authors.forename: P F
authors.initials: PF
authors.lastname: Halloran
authors.forename: P E
authors.initials: PE
authors.lastname: Birk
authors.forename: P M
authors.initials: PM
authors.lastname: Campbell
authors.forename: M
authors.initials: M
authors.lastname: Cascalho
authors.forename: A B
authors.initials: AB
authors.lastname: Collins
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: C B
authors.initials: CB
authors.lastname: Drachenberg
authors.forename: I W
authors.initials: IW
authors.lastname: Gibson
authors.forename: P C
authors.initials: PC
authors.lastname: Grimm
authors.forename: M
authors.initials: M
authors.lastname: Haas
authors.forename: E
authors.initials: E
authors.lastname: Lerut
authors.forename: H
authors.initials: H
authors.lastname: Liapis
authors.forename: R B
authors.initials: RB
authors.lastname: Mannon
authors.forename: P B
authors.initials: PB
authors.lastname: Marcus
authors.forename: M
authors.initials: M
authors.lastname: Mengel
authors.forename: M J
authors.initials: MJ
authors.lastname: Mihatsch
authors.forename: B J
authors.initials: BJ
authors.lastname: Nankivell
authors.forename: V
authors.initials: V
authors.lastname: Nickeleit
authors.forename: J C
authors.initials: JC
authors.lastname: Papadimitriou
authors.forename: J L
authors.initials: JL
authors.lastname: Platt
authors.forename: P
authors.initials: P
authors.lastname: Randhawa
authors.forename: I
authors.initials: I
authors.lastname: Roberts
authors.forename: L
authors.initials: L
authors.lastname: Salinas-Madriga
authors.forename: D R
authors.initials: DR
authors.lastname: Salomon
authors.forename: D
authors.initials: D
authors.lastname: Seron
authors.forename: M
authors.initials: M
authors.lastname: Sheaff
authors.forename: J J
authors.initials: JJ
authors.lastname: Weening
mesh_terms: D000906:Antibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005355:Fibrosis; D005819:Genetic Markers; D006084:Graft Rejection / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000276:immunology / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D016030:Kidney Transplantation; D016377:Organ Transplantation
chemical_list: D000906:Antibodies; D005819:Genetic Markers